OnCusp Therapeutics

Oncko

This company develops multi-drug cancer therapies and clinical platform trials to identify optimal treatment combinations and schedules for pharmaceutical partners and patients.

Cumulus Oncology

This company develops preclinical oncology assets and creates spin-out biotechnology firms to advance cancer treatments for pharmaceutical partners and patients.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.

Catalyst Oncology

The company provides clinical research services for oncology trials to biotechnology and pharmaceutical firms developing cancer treatments.

Ratio Therapeutics

This clinical-stage pharmaceutical company develops targeted radiotherapies and diagnostics to treat cancer for the oncology market and global pharmaceutical partners.

Momentous Therapeutics

This company develops pan-cancer drugs and therapeutic treatments for the pharmaceutical industry to address challenging biological targets.

MyCural Therapeutics

This company develops small molecule drugs targeting the MYC oncoprotein to treat patients with aggressive, high-risk cancers.

Taveren Therapeutics

The company develops oncology drug candidates that reactivate natural tumour suppressors for pharmaceutical partners and cancer patients.